Skip to main navigation Skip to search Skip to main content

Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease

  • Kangbuk Samsung Hospital
  • Yonsei University

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science